APTINYX INC (APTX)

US03836N1037 - Common Stock

0.061  -0.04 (-39%)

After market: 0.074 +0.01 (+21.31%)

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

News Image
a year ago - InvestorPlace

AMC Stock Alert: AMC Entertainment Launches Popcorn Line at Walmart

AMC Entertainment (AMC) stock is in the news after the movie theater company announced it will launch its own line of popcorn at Walmart.

News Image
a year ago - InvestorPlace

Why Is AdaptHealth (AHCO) Stock Down 22% Today?

AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.

News Image
a year ago - InvestorPlace

Why Is Aptinyx (APTX) Stock Down 64% Today?

Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

News Image
a year ago - Seeking Alpha

APTX stock falls as Phase 2 trial for Parkinson's disease and dementia fails (NASDAQ:APTX)

Aptinyx (APTX) lost Tuesday after a setback for its Phase 2 trial for NYX-458 in cognitive impairment linked to Parkinson’s disease and dementia with Lewy bodies. Read the full story here.